Skip to Main Content

Author Details

Kenneth J Pienta
The Brady Urological Institute, Johns Hopkins University School of Medicine
1981
638
121
PMIDPaper TitleJournal TitlePublished Year
37679601Application of next-generation imaging in biochemically recurrent prostate cancer.Prostate Cancer Prostatic Dis2024
37758847Diagnostic liquid biopsy biomarkers in renal cell cancer.Nat Rev Urol2024
37558543Identification of a Predictive Genomic Biomarker for Prostate-directed Therapy in Synchronous Low-volume Metastatic Castration-sensitive Prostate Cancer.Eur Urol Oncol2024
38050147Comparison of Multiple Segmentation Methods for Volumetric Delineation of Primary Prostate Cancer with Prostate-Specific Membrane Antigen-Targeted <sup>18</sup>F-DCFPyL PET/CT.J Nucl Med2024
37679602Biochemical recurrence in patients with prostate cancer after primary definitive therapy: treatment based on risk stratification.Prostate Cancer Prostatic Dis2024
36372998Presence of cells in the polyaneuploid cancer cell (PACC) state predicts the risk of recurrence in prostate cancer.Prostate2023
37700000A mathematical investigation of polyaneuploid cancer cell memory and cross-resistance in state-structured cancer populations.Sci Rep2023
37829179The contribution of evolvability to the eco-evolutionary dynamics of competing species.Ecol Evol2023
37644281Targeting MerTK decreases efferocytosis and increases anti-tumor immune infiltrate in prostate cancer.Med Oncol2023
37568766Cell State and Cell Type: Deconvoluting Circulating Tumor Cell Populations in Liquid Biopsies by Multi-Omics.Cancers (Basel)2023
37971875MYC-driven increases in mitochondrial DNA copy number occur early and persist throughout prostatic cancer progression.JCI Insight2023
37564061<i>Escherichia coli</i> survival in response to ciprofloxacin antibiotic stress correlates with increased nucleoid length and effective misfolded protein management.R Soc Open Sci2023
37326720Cells in the polyaneuploid cancer cell (PACC) state have increased metastatic potential.Clin Exp Metastasis2023
37211963Test-retest repeatability of organ uptake on PSMA-targeted <sup>18</sup> F-DCFPyL PET/CT in patients with prostate cancer.Prostate2023
37414701Prostate-specific Membrane Antigen Reporting and Data System Version 2.0.Eur Urol2023
37012549Neoadjuvant enoblituzumab in localized prostate cancer: a single-arm, phase 2 trial.Nat Med2023
37409952Updating the Definition of Cancer.Mol Cancer Res2023
37173210Clinical and Genomic Differences Between Advanced Molecular Imaging-detected and Conventional Imaging-detected Metachronous Oligometastatic Castration-sensitive Prostate Cancer.Eur Urol2023
37172462Nuclear morphology predicts cell survival to cisplatin chemotherapy.Neoplasia2023
37168944Novel urinary tract obstruction marker discovery by multi-marker profiling of urinary extracellular vesicles derived from a rat UTO model.Am J Clin Exp Urol2023
37165552Baseline PSMA-PET/CT as a predictor of PSA persistence following radical prostatectomy in high-risk nonmetastatic prostate cancer patients receiving neoadjuvant therapy.Prostate2023
37164128Transcriptomic and clinical heterogeneity of metastatic disease timing within metastatic castration-sensitive prostate cancer.Ann Oncol2023
36857019Multi-timepoint imaging with PSMA-targeted [<sup>18</sup>F]F-Florastamin PET/CT: lesion detection and comparison to conventional imaging.Ann Nucl Med2023
36621992Reply by Authors.J Urol2023
36621991Pathological Effects of Apalutamide in Lower-risk Prostate Cancer: Results From a Phase II Clinical Trial.J Urol2023
36443902Exploring new frontiers in prostate cancer research: Report from the 2022 Coffey-Holden prostate cancer academy meeting.Prostate2023
36853375Modeling cancer's ecological and evolutionary dynamics.Med Oncol2023
36840972Bone marrow niche chemoprotection of metastatic solid tumors mediated by CYP3A4.Cancer2023
36708787WNT Pathway Mutations in Metachronous Oligometastatic Castration-Sensitive Prostate Cancer.Int J Radiat Oncol Biol Phys2023
36865273MYC-driven increases in mitochondrial DNA copy number occur early and persist throughout prostatic cancer progression.bioRxiv2023
36632656Lack of repeatability of radiomic features derived from PET scans: Results from a <sup>18</sup> F-DCFPyL test-retest cohort.Prostate2023
36598661Dormant cancer cells: programmed quiescence, senescence, or both?Cancer Metastasis Rev2023
36894033An Enhancing Renal Mass in Metastatic Prostate Cancer.Urology2023
33279670Cancer cell foraging to explain bone-specific metastatic progression.Bone2022
35738192Withdrawal: The role of CXCR7/RDC1 as a chemokine receptor for CXCL12/SDF-1 in prostate cancer.J Biol Chem2022
35478055Interim analysis of companion, prospective, phase II, clinical trials assessing the efficacy and safety of multi-modal total eradication therapy in men with synchronous oligometastatic prostate cancer.Med Oncol2022
35603510Piflufolastat F-18 (<sup>18</sup>F-DCFPyL) for PSMA PET imaging in prostate cancer⿯.Expert Rev Anticancer Ther2022
35754042Neuropilin-2 regulates androgen-receptor transcriptional activity in advanced prostate cancer.Oncogene2022
35563113Interplay between Cell Death and Cell Proliferation Reveals New Strategies for Cancer Therapy.Int J Mol Sci2022
35810282Optimized data-independent acquisition approach for proteomic analysis at single-cell level.Clin Proteomics2022
36580220Deep learning and radiomics framework for PSMA-RADS classification of prostate cancer on PSMA PET.EJNMMI Res2022
36425924RNA profiling of circulating tumor cells systemically captured from diagnostic leukapheresis products in prostate cancer patients.Mater Today Bio2022
36412679Association of True Positivity with Serum Prostate-Specific Antigen Levels and Other Clinical Factors in Indeterminate PSMA-RADS-3A Lesions Identified on <sup>18</sup>F-DCFPyL PET/CT Scans.Tomography2022
36111404Retraction: Characterization of Phosphoglycerate Kinase-1 Expression of Stromal Cells Derived from Tumor Microenvironment in Prostate Cancer Progression.Cancer Res2022
35972622Origin and evolution of animal multicellularity in the light of phylogenomics and cancer genetics.Med Oncol2022
36001857Long-Term Outcomes and Genetic Predictors of Response to Metastasis-Directed Therapy Versus Observation in Oligometastatic Prostate Cancer: Analysis of STOMP and ORIOLE Trials.J Clin Oncol2022
35939881Targeting interleukin 4 receptor alpha on tumor-associated macrophages reduces the pro-tumor macrophage phenotype.Neoplasia2022
35906318Stochastic models of Mendelian and reverse transcriptional inheritance in state-structured cancer populations.Sci Rep2022
35962062A life history model of the ecological and evolutionary dynamics of polyaneuploid cancer cells.Sci Rep2022
36229102<sup>18</sup>F-Labeled Radiotracers for Prostate-specific Membrane Antigen: Historical Perspective and Future Directions.PET Clin2022
  • 1 - 50 of 638

Recommended Authors

Arun A Azad
Peter MacCallum Cancer Centre
Career Start Year 2007
Number of shared co-authors 22
Mitchell G Lawrence
Biomedicine Discovery Institute, Monash University
Career Start Year 2005
Number of shared co-authors 8
Hui Xue
Agricultural Genomics Institute at Shenzhen, Chinese Academy of Agricultural Sciences
Career Start Year 2005
Number of shared co-authors 45
Michael C Haffner
Fred Hutchinson Cancer Center
Career Start Year 2005
Number of shared co-authors 68
Robert H Bell
University of British Columbia
Career Start Year 2004
Number of shared co-authors 25
Anne Y Warren
Cambridge University Hospitals National Health Service Foundation Trust
Career Start Year 2003
Number of shared co-authors 15
Antonio Hurtado-Coll
University of British Columbia
Career Start Year 2002
Number of shared co-authors 29
Ladan Fazli
University of British Columbia
Career Start Year 2002
Number of shared co-authors 60
Tomasz M Beer
OHSU Knight Cancer Institute, Oregon Health & Science University
Career Start Year 2000
Number of shared co-authors 77
Eleni Efstathiou
Houston Methodist Cancer Center
Career Start Year 2000
Number of shared co-authors 44
Renea A Taylor
Peter MacCallum Cancer Centre
Career Start Year 1999
Number of shared co-authors 10
Hayley C Whitaker
University College London
Career Start Year 1999
Number of shared co-authors 7
Anthony M Joshua
The Kinghorn Cancer Centre, St. Vincent's Hospital Sydney
Career Start Year 1997
Number of shared co-authors 31
Matthew B Rettig
David Geffen School of Medicine, University of California los angeles
Career Start Year 1995
Number of shared co-authors 91
Stanley K Liu
Odette Cancer Centre, University of Toronto
Career Start Year 1995
Number of shared co-authors 6
Ganesh V Raj
University of Texas Southwestern Medical Center at Dallas
Career Start Year 1994
Number of shared co-authors 43
David I Quinn
USC Norris Comprehensive Cancer Center
Career Start Year 1993
Number of shared co-authors 37
Bhaskar Kallakury
Georgetown University
Career Start Year 1993
Number of shared co-authors 1
Marshall Scott Lucia
University of Colorado School of Medicine
Career Start Year 1991
Number of shared co-authors 13
Adrie van Bokhoven
University of Colorado Anschutz Medical Campus
Career Start Year 1988
Number of shared co-authors 2
Christopher P Evans
University of California Davis
Career Start Year 1988
Number of shared co-authors 53
Freddie C Hamdy
University of Oxford
Career Start Year 1987
Number of shared co-authors 27
Michael R Freeman
Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center
Career Start Year 1987
Number of shared co-authors 35
Armen Aprikian
McGill University Health Centre, McGill University
Career Start Year 1987
Number of shared co-authors 9
Anders Bjartell
Skane University Hospital, Lund University
Career Start Year 1987
Number of shared co-authors 54
Dominique Trudel
Institut du cancer de Montreal
Career Start Year 1985
Number of shared co-authors 12
David M Berman
Queen's University
Career Start Year 1982
Number of shared co-authors 27
Christopher S Foster
The Institute of Cancer Research
Career Start Year 1978
Number of shared co-authors 13
Anne E Cress
University of Arizona Cancer Center, College of Medicine, University of Arizona
Career Start Year 1977
Number of shared co-authors 6
William E Grizzle
University of Alabama at Birmingham
Career Start Year 1974
Number of shared co-authors 5

Collaborators

Arul M Chinnaiyan
University of Michigan Medical School.
Co-authored papers 43
David C Smith
Rogel Comprehensive Cancer Center, University of Michigan ann arbor
Co-authored papers 33
Mark A Rubin
University of Bern
Co-authored papers 33
Ashley E Ross
Northwestern University
Co-authored papers 26
Scott A Tomlins
Rogel Cancer Center, University of Michigan Medical School ann arbor
Co-authored papers 25
Rohit Mehra
Michigan Center for Translational Pathology.
Co-authored papers 23
Phuoc T Tran
University of Maryland School of Medicine
Co-authored papers 22
Emmanuel S Antonarakis
The Sidney Kimmel Cancer Comprehensive Cancer Center at Johns Hopkins
Co-authored papers 20
Xuhong Cao
Michigan Center for Translational Pathology.
Co-authored papers 19
Mario A Eisenberger
Johns Hopkins University
Co-authored papers 18
Javed Siddiqui
Michigan Center for Translational Pathology, University of Michigan ann arbor
Co-authored papers 17
Mark C Markowski
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Co-authored papers 16
Maha Hussain
Northwestern University
Co-authored papers 16
Felix Y Feng
UCSF Medical Center-Mount Zion
Co-authored papers 15
Danny Y Song
Johns Hopkins University School of Medicine
Co-authored papers 14
Michael A Carducci
Johns Hopkins School of Medicine
Co-authored papers 14
Sooryanarayana Varambally
University of Alabama at Birmingham, USA O'Neal Comprehensive Cancer Center
Co-authored papers 14
Theodore L DeWeese
Johns Hopkins University School of Medicine
Co-authored papers 13
Matthew P Deek
Rutgers Robert Wood Johnson Medical School, Rutgers University
Co-authored papers 12
Robert J Lonigro
Michigan Center for Translational Pathology, University of Michigan ann arbor
Co-authored papers 12
Jianhua Wang
Anhui University of Science & Technology
Co-authored papers 12
Saravana M Dhanasekaran
Co-authored papers 12
Ryan Phillips
Johns Hopkins University
Co-authored papers 11
Channing J Paller
Johns Hopkins University School of Medicine
Co-authored papers 11
Curtiland Deville
Johns Hopkins University
Co-authored papers 10
Theo M de Reijke
Amsterdam University Medical Centers, University of Amsterdam
Co-authored papers 10
Howard M Sandler
Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center
Co-authored papers 10
Lakshmi P Kunju
Michigan Center for Translational Pathology, University of Michigan ann arbor
Co-authored papers 9
Edward M Schaeffer
Northwestern University Feinberg School of Medicine
Co-authored papers 9
Tamara L Lotan
Johns Hopkins University School of Medicine
Co-authored papers 9
Release 1.2